O. Becquart

572 total citations
11 papers, 99 citations indexed

About

O. Becquart is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, O. Becquart has authored 11 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in O. Becquart's work include Nonmelanoma Skin Cancer Studies (3 papers), Cancer and Skin Lesions (2 papers) and Neuroblastoma Research and Treatments (2 papers). O. Becquart is often cited by papers focused on Nonmelanoma Skin Cancer Studies (3 papers), Cancer and Skin Lesions (2 papers) and Neuroblastoma Research and Treatments (2 papers). O. Becquart collaborates with scholars based in France, United States and United Kingdom. O. Becquart's co-authors include B. Guillot, O. Dereure, C. Lesage, Laure Cayrefourcq, Laurent Meunier, Catherine Alix‐Panabières, Jean‐François Eliaou, Catherine W. Morgans, Christina Zeitz and Christelle Michiels and has published in prestigious journals such as PLoS ONE, Cancers and OncoImmunology.

In The Last Decade

O. Becquart

11 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Becquart France	6	58	30	25	24	13	11	99
Esther Hian Li Chan Singapore	6	66 1.1×	27 0.9×	28 1.1×	25 1.0×	5 0.4×	17	106
Nathan R. Fons United States	4	25 0.4×	31 1.0×	11 0.4×	12 0.5×	14 1.1×	5	81
Robert J. Autry United States	6	25 0.4×	68 2.3×	12 0.5×	14 0.6×	37 2.8×	12	127
Tomoya Isobe Japan	6	18 0.3×	55 1.8×	7 0.3×	15 0.6×	29 2.2×	10	90
Anne Song United States	4	30 0.5×	60 2.0×	49 2.0×	9 0.4×	18 1.4×	4	130
Elen Oliveira Brazil	4	35 0.6×	24 0.8×	10 0.4×	22 0.9×	10 0.8×	5	100
Benjamin Kahn United States	5	38 0.7×	46 1.5×	18 0.7×	9 0.4×	21 1.6×	11	103
Logan Zhang United States	5	63 1.1×	35 1.2×	28 1.1×	17 0.7×	11 0.8×	5	123
Hilary Racher Canada	3	47 0.8×	38 1.3×	10 0.4×	8 0.3×	15 1.2×	3	109
Waleed M. Kholosy Netherlands	5	29 0.5×	34 1.1×	30 1.2×	31 1.3×	9 0.7×	7	88

Countries citing papers authored by O. Becquart

Since Specialization

Citations

This map shows the geographic impact of O. Becquart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Becquart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Becquart more than expected).

Fields of papers citing papers by O. Becquart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Becquart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Becquart. The network helps show where O. Becquart may publish in the future.

Co-authorship network of co-authors of O. Becquart

This figure shows the co-authorship network connecting the top 25 collaborators of O. Becquart. A scholar is included among the top collaborators of O. Becquart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Becquart. O. Becquart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Momjian, Shahan, Assma Ben Aïssa, O. Becquart, et al.. (2023). Pituitary macroadenoma apoplexy following treatment with pembrolizumab. Endocrine Abstracts. 1 indexed citations

2.

Becquart, O., Stéphane Dalle, Laurent Mortier, et al.. (2021). Tolerance and Effectiveness of Targeted Therapies in Aged Patients with Metastatic Melanoma. Cancers. 13(12). 3042–3042. 5 indexed citations

3.

Reynolds, Margaret, Sarah Tick, O. Becquart, et al.. (2020). Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy. PLoS ONE. 15(4). e0231750–e0231750. 13 indexed citations

4.

Becquart, O. & B. Guillot. (2020). Carcinoma epidermoide cutáneo y sus precursores. 54(1). 1–19. 2 indexed citations

5.

Becquart, O., et al.. (2020). Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases. Melanoma Research. 30(5). 519–523. 5 indexed citations

6.

Cayrefourcq, Laure, et al.. (2020). Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma. Cancers. 12(4). 960–960. 25 indexed citations

7.

Becquart, O., B. Guillot, J.‐L. Bourrain, Claire Duflos, & A. Du‐Thanh. (2019). Risque de cancers cutanés sous hydrochlorothiazide : revue systématique. La Revue de Médecine Interne. 40(9). 617–622. 2 indexed citations

8.

Becquart, O., et al.. (2019). Myasthenia Gravis Induced by Immune Checkpoint Inhibitors. Journal of Immunotherapy. 42(8). 309–312. 34 indexed citations

9.

Becquart, O., et al.. (2018). Traitement intermittent par vismodégib des carcinomes basocellulaires (CBC) avancés : efficacité et tolérance. Annales de Dermatologie et de Vénéréologie. 145(12). S96–S97. 1 indexed citations

10.

Michaud, Henri‐Alexandre, O. Becquart, Virginie Lafont, et al.. (2017). PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. OncoImmunology. 6(10). e1353857–e1353857. 10 indexed citations

11.

Becquart, O., B. Cribier, B. Guillot, & C. Girard. (2015). Rémission complète et prolongée d’un carcinome trichoblastique métastatique traité par vismodegib. Annales de Dermatologie et de Vénéréologie. 142(12). S517–S517. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact